CATALIST-LISTED medtech company QT Vascular 5I0 : 5I0 0%is staring down a possible do-over of a recent extraordinary general meeting (EGM), said its board in an update released on Tuesday (Dec 7).

The board said it got an e-mail on Monday afternoon from would-be director Christian Kwok-Leun Yau Heilesen, seeking a fresh vote on the resolutions that had failed to pass muster that very morning.

Requisitioning shareholders Mission Well Ltd and Tansri Saridju Benui had last month called for an EGM for shareholders to decide on appointing Tansri, Mission Well director Heilesen, and 3 others to the board. The 5 resolutions were rejected at the EGM on Monday.

QT Vascular "has been in consultation with its professional advisers to determine the validity of this attempt to convene" a new EGM, the board disclosed. It also said that QT Vascular wants an explanation for the second EGM attempt from Mission Well and Tansri.

Besides the nomination of the 5 directors, Mission Well and Tansri also sought the ouster of then-chief executive Eitan Konstantino and 3 others. While Konstantino has since stepped down from his role, there will be another EGM on Dec 15 over the board seats held by executive director Momi Mimon Brosh and independent directors Eric Sho Kian Hin and Ng Boon Eng.

The board said in a statement signed by Sho that QT Vascular would keep updating shareholders on material developments "as and when appropriate", and advised investors to exercise caution when dealing in the securities of the company.

GET BT IN YOUR INBOX DAILY

Start and end each day with the latest news stories and analyses delivered straight to your inbox.

Sign UpVIEW ALL

QT Vascular called a trading halt on Monday morning "pending the release of announcements". 

READ MORE;

• QT Vascular nominating committee raises concerns over proposed new directors ahead of EGM

• QT Vascular shareholders vote to reject 5 would-be directors in ongoing board tussle